Alnylam Pharmaceuticals $303.64 (+11.06, 3.78%)

Open Long

Date

Item Count

Trend Origin

Slope

Trend Sigma

Correlation Percent

Forecast Optimal Move

Forecast Sigma

Profit Or Loss Optimal Move

Profit Or Loss Percentage Gain

Profit Or Loss Periods

Reverse Forecast Optimal Move

Reverse Forecast Sigma

Reverse Profit Or Loss Optimal Move

Reverse Profit Or Loss Percentage Gain

Reverse Profit Or Loss Periods

ALNY @ NASDAQ Analysis 2* Analysis for Alnylam Pharmaceuticals Analyses